Bookbot

Ernst Schering Research Foundation Workshop Supplement - 7: New Concepts in Pathology and Treatment of Autoimmune Disorders

Parameters

  • 139bladzijden
  • 5 uur lezen

Meer over het boek

Autoimmunity, characterized by autoreactive lymphocytes and autoantibodies, is the consequence of a failure to discriminate between self and non-self, and autoimmune diseases are an increasing threat to people living in the industrialized countries. Autoimmune disorders are treatable, but not curable, and patients can face disability at later stages of the disease. Thus, there is a medical and economic need for new concepts and treatments in autoimmune disorders. New concepts and treatments can only be achieved by an interdisciplinary approach bringing together expertise, technologies, and clinical experience. The workshop focused on multiple sclerosis, rheumatoid arthritis and type I diabetes, and discussed conventional drug therapies, gene therapy, cell and tissue transplantation therapies, and first treatments using blood stem cells for reprogramming the patients' immune system.

Een boek kopen

Ernst Schering Research Foundation Workshop Supplement - 7: New Concepts in Pathology and Treatment of Autoimmune Disorders, Paolo Pozzilli, Carlo Pozzilli, J.-F. Kapp

Taal
Jaar van publicatie
2001
Bindwijze
(Hardcover),
Staat van het boek
Goed
Prijs
€ 12,99

Betaalmethoden

Nog niemand heeft beoordeeld.Tarief

Titel
Ernst Schering Research Foundation Workshop Supplement - 7: New Concepts in Pathology and Treatment of Autoimmune Disorders
Taal
Engels
Uitgever
Springer
Jaar van publicatie
2001
Formaat
Hardcover
Aantal pagina's
139
ISBN10
3540414797
ISBN13
9783540414797
Reeks
Aantekening
Autoimmunity, characterized by autoreactive lymphocytes and autoantibodies, is the consequence of a failure to discriminate between self and non-self, and autoimmune diseases are an increasing threat to people living in the industrialized countries. Autoimmune disorders are treatable, but not curable, and patients can face disability at later stages of the disease. Thus, there is a medical and economic need for new concepts and treatments in autoimmune disorders. New concepts and treatments can only be achieved by an interdisciplinary approach bringing together expertise, technologies, and clinical experience. The workshop focused on multiple sclerosis, rheumatoid arthritis and type I diabetes, and discussed conventional drug therapies, gene therapy, cell and tissue transplantation therapies, and first treatments using blood stem cells for reprogramming the patients' immune system.